Works matching DE "TREATMENT of chronic myeloid leukemia"

Results: 752

Advancing Leukemia Management Through Liquid Biopsy: Insights into Biomarkers and Clinical Utility.

Published in:

Cancers, 2025, v. 17, n. 9, p. 1438, doi. 10.3390/cancers17091438

By:

Hollanda, Cíntia Nogueira;
Gualberto, Ana Cristina Moura;
Motoyama, Andréa Barretto;
Pittella-Silva, Fabio

Publication type:

Article

A rare case of imatinib-induced erythroderma.

Published in:

2013

By:

Verma, Rajesh;
Vasudevan, Biju;
Pragasam, Vijendran;
Neema, Shekhar

Publication type:

Case Study

A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 221, doi. 10.1007/s00280-011-1688-7

By:

Abbas, Richat;
Hug, Bruce;
Leister, Cathie;
Gaaloul, Myriam;
Chalon, Stephan;
Sonnichsen, Daryl

Publication type:

Article

Imatinib mesylate enhances the malignant behavior of human breast carcinoma cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 919, doi. 10.1007/s00280-010-1394-x

By:

Rappa, Germana;
Anzanello, Fabio;
Lorico, Aurelio

Publication type:

Article

Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling.

Published in:

Journal of Pharmacy & Pharmacology, 2017, v. 69, n. 10, p. 1265, doi. 10.1111/jphp.12757

By:

Boons, Christel C.L.M.;
Chahbouni, Abdel;
Schimmel, Anneliene M.;
Wilhelm, Abraham J.;
Hartog, Yvonne M.;
Janssen, Jeroen J.W.M.;
Hendrikse, N. Harry;
Hugtenburg, Jacqueline G.;
Swart, Eleonora L.

Publication type:

Article

Increasing Access to Care for Chronic Myeloid Leukemia Patients: Assessment of a Scaling-up Program.

Published in:

Journal of Health Care for the Poor & Underserved, 2013, v. 24, n. 4, p. 1486, doi. 10.1353/hpu.2013.0160

By:

Ladner, Joël;
Tekinturhan, Ebru;
Tavolacci, Marie-Pierre;
Audureau, Etienne;
Saba, Joseph

Publication type:

Article

Primary imatinib resistance in chronic myeloid leukemia patients in a developing country: BCR-ABL kinase domain mutations or BCR-ABL independent mechanisms?

Published in:

Malaysian Journal of Pathology, 2017, v. 39, n. 2, p. 107

By:

Yap, E.;
Tumian, N. R.;
Azma, R. Z.;
Sharifah, N. A.;
Salwati, S.;
Hamidah, N. H.;
Elias, M. H.;
Wong, C. L.

Publication type:

Article

Real-time quantification for BCR-ABL transcripts in chronic myeloid leukaemia patients in UKMMC, Malaysia.

Published in:

Malaysian Journal of Pathology, 2011, v. 33, n. 2, p. 107

By:

Wong, F. L.;
Hamidah, N. H.;
Hawa, A. A.;
Nurul, A. N.;
Leong, C. F.;
Fadilah, Saw;
Ainoon, O.

Publication type:

Article

Oral Implant Treatment for a Patient Undergoing Molecularly Targeted Drug Therapy for Chronic Myelocytic Leukemia: A Case Report.

Published in:

2020

By:

Koji Morita;
Hiroki Tsuka;
Koi-chi Kuremoto;
Kazuhiro Tsuga;
Morita, Koji;
Tsuka, Hiroki;
Kuremoto, Koi-Chi;
Tsuga, Kazuhiro

Publication type:

journal article

Transient severe non-proliferative retinopathy in an adolescent with type 1 diabetes and chronic myeloid leukemia.

Published in:

Pediatric Diabetes, 2013, v. 14, n. 3, p. 227, doi. 10.1111/j.1399-5448.2012.00901.x

By:

Schmid, Silvia;
Lang‐Muritano, Mariarosaria;
Meier, Urs;
De Peron, Riccardo;
Konrad, Daniel;
Schoenle, Eugen

Publication type:

Article

Thyroid Function Abnormalities Associated with Ponatinib Therapy in Patients with Chronic Myeloid Leukemia.

Published in:

Thyroid, 2015, v. 25, n. 6, p. 706, doi. 10.1089/thy.2014.0514

By:

Palani, Renuka;
Apperley, Jane F.;
Reid, Alistair;
Foroni, Letizia;
Deplano, Simona;
Milojkovic, Dragana

Publication type:

Article

Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia.

Published in:

Thyroid, 2010, v. 20, n. 11, p. 1209, doi. 10.1089/thy.2010.0251

By:

Theo D. Kim;
Michaela Schwarz;
Hendrik Nogai;
Peggy Grille;
Jörg Westermann;
Ursula Plöckinger;
Doreen Braun;
Ulrich Schweizer;
Renate Arnold;
Bernd Dörken;
Philipp le Coutre

Publication type:

Article

Chronic Neutrophilic Leukemia: Advances in Diagnosis, Genetic Insights, and Management Strategies.

Published in:

Cancers, 2025, v. 17, n. 2, p. 227, doi. 10.3390/cancers17020227

By:

Elbaz Younes, Ismail;
Mroz, Pawel;
Tashakori, Mehrnoosh;
Hamed, Amira;
Sen, Siddhartha

Publication type:

Article

Artificial Intelligence-Based Management of Adult Chronic Myeloid Leukemia: Where Are We and Where Are We Going?

Published in:

Cancers, 2024, v. 16, n. 5, p. 848, doi. 10.3390/cancers16050848

By:

Bernardi, Simona;
Vallati, Mauro;
Gatta, Roberto

Publication type:

Article

The Contemporary Role of Hematopoietic Stem Cell Transplantation in the Management of Chronic Myeloid Leukemia: Is It the Same in All Settings?

Published in:

Cancers, 2024, v. 16, n. 4, p. 754, doi. 10.3390/cancers16040754

By:

Elmakaty, Ibrahim;
Saglio, Giuseppe;
Al-Khabori, Murtadha;
Elsayed, Abdelrahman;
Elsayed, Basant;
Elmarasi, Mohamed;
Elsabagh, Ahmed Adel;
Alshurafa, Awni;
Ali, Elrazi;
Yassin, Mohamed

Publication type:

Article

Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component.

Published in:

Cancers, 2022, v. 14, n. 24, p. 6244, doi. 10.3390/cancers14246244

By:

Platte, Victoria;
Bergmann, Anika;
Hildebrandt, Barbara;
Wieczorek, Dagmar;
Schuler, Esther;
Germing, Ulrich;
Kaivers, Jennifer;
Haas, Rainer;
Kobbe, Guido;
Schroeder, Thomas;
Rautenberg, Christina

Publication type:

Article

Meta-Analytic Comparison of Global RNA Transcriptomes of Acute and Chronic Myeloid Leukemia Cells Reveals Novel Gene Candidates Governing Myeloid Malignancies.

Published in:

Cancers, 2022, v. 14, n. 19, p. 4681, doi. 10.3390/cancers14194681

By:

Jurgec, Staša;
Jezernik, Gregor;
Gorenjak, Mario;
Büdefeld, Tomaž;
Potočnik, Uroš

Publication type:

Article

Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia.

Published in:

Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143300

By:

Poudel, Govinda;
Tolland, Molly G.;
Hughes, Timothy P.;
Pagani, Ilaria S.

Publication type:

Article

Droplet Digital PCR for BCR–ABL1 Monitoring in Diagnostic Routine: Ready to Start?

Published in:

Cancers, 2021, v. 13, n. 21, p. 5470, doi. 10.3390/cancers13215470

By:

Bochicchio, Maria Teresa;
Petiti, Jessica;
Berchialla, Paola;
Izzo, Barbara;
Giugliano, Emilia;
Ottaviani, Emanuela;
Errichiello, Santa;
Rege-Cambrin, Giovanna;
Venturi, Claudia;
Luciano, Luigiana;
Daraio, Filomena;
Calistri, Daniele;
Rosti, Gianantonio;
Saglio, Giuseppe;
Martinelli, Giovanni;
Pane, Fabrizio;
Cilloni, Daniela;
Gottardi, Enrico M.;
Fava, Carmen

Publication type:

Article

Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML).

Published in:

Cancers, 2021, v. 13, n. 7, p. 1610, doi. 10.3390/cancers13071610

By:

Bewersdorf, Jan Philipp;
Zeidan, Amer M.;
Colomo, Luis;
Calvo, Xavier

Publication type:

Article

PVR and ICAM-1 on Blast Crisis CML Stem and Progenitor Cells with TKI Resistance Confer Susceptibility to NK Cells.

Published in:

Cancers, 2020, v. 12, n. 7, p. 1923, doi. 10.3390/cancers12071923

By:

Kim, Nayoung;
Kim, Mi-Yeon;
Cho, Young-Uk;
Chen, WenYong;
Lee, Kyoo-Hyung;
Kim, Hun Sik

Publication type:

Article

HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?

Published in:

Cancers, 2020, v. 12, n. 2, p. 318, doi. 10.3390/cancers12020318

By:

Losson, Hélène;
Schnekenburger, Michael;
Dicato, Mario;
Diederich, Marc

Publication type:

Article

Simultaneous Inhibition of BCR-ABL1 Tyrosine Kinase and PAK1/2 Serine/Threonine Kinase Exerts Synergistic Effect against Chronic Myeloid Leukemia Cells.

Published in:

Cancers, 2019, v. 11, n. 10, p. 1544, doi. 10.3390/cancers11101544

By:

Flis, Sylwia;
Bratek, Ewelina;
Chojnacki, Tomasz;
Piskorek, Marlena;
Skorski, Tomasz

Publication type:

Article

Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis.

Published in:

Leukemia Research & Treatment, 2015, p. 1, doi. 10.1155/2015/982395

By:

Rochau, Ursula;
Kluibenschaedl, Martina;
Stenehjem, David;
Kuan-Ling, Kuo;
Radich, Jerald;
Oderda, Gary;
Brixner, Diana;
Siebert, Uwe

Publication type:

Article

Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia.

Published in:

Leukemia Research & Treatment, 2015, p. 1, doi. 10.1155/2015/757694

By:

Khajapeer, Kalubai Vari;
Baskaran, Rajasekaran

Publication type:

Article

The Danish National Chronic Myeloid Neoplasia Registry.

Published in:

Clinical Epidemiology, 2016, v. 8, p. 567, doi. 10.2147/CLEP.S99462

By:

Bak, Marie;
Ibfelt, Else Helene;
Stauffer Larsen, Thomas;
Rønnov-Jessen, Dorthe;
Pallisgaard, Niels;
Madelung, Ann;
Udby, Lene;
Hasselbalch, Hans Carl;
Bjerrum, Ole Weis;
Lykkegaard Andersen, Christen

Publication type:

Article

Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors - The first molecular targeted treatment.

Published in:

Journal of Medicine & Life, 2010, v. 3, n. 2, p. 162

By:

Bumbea, Horia;
Vladareanu, Ana-Maria;
Voican, Irina;
Cisleanu, Diana;
Barsan, Lavinia;
Onisai, Minodora

Publication type:

Article

Bilateral Proliferative Retinopathy as the Initial Presentation of Chronic Myeloid Leukemia.

Published in:

2013

By:

Macedo, Mafalda S. F.;
Figueiredo, Ana R. M.;
Ferreira, Natália N.;
Barbosa, Irene M. A.;
Furtado, Maria João F. B. S.;
Correia, Nuno F. C. B. A.;
Gomes, Miguel P.;
Lume, Miguel R. B.;
Menéres, Maria João S.;
Santos, Marinho M. N.;
Meireles, M. Angelina C. S.

Publication type:

Case Study

THERAPEUTIC SUCCESS IN CHRONIC MYELOID LEUKAEMIA-ACCELERATED PHASE AT ONSET.

Published in:

Therapeutics, Pharmacology & Clinical Toxicology, 2014, v. 18, n. 2, p. 83

By:

Oana, Patrinoiu;
Daniela, Georgescu

Publication type:

Article

Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling

Published in:

Molecular Oncology, 2012, v. 6, n. 3, p. 276, doi. 10.1016/j.molonc.2012.02.002

By:

Nam, Sangkil;
Scuto, Anna;
Yang, Fan;
Chen, WenYong;
Park, Sungman;
Yoo, Hwa-Seung;
Konig, Heiko;
Bhatia, Ravi;
Cheng, Xinlai;
Merz, Karl-Heinz;
Eisenbrand, Gerhard;
Jove, Richard

Publication type:

Article

Targeted Therapies: The Rare Cancer Paradigm

Published in:

Molecular Oncology, 2010, v. 4, n. 1, p. 19, doi. 10.1016/j.molonc.2009.10.003

By:

Pierotti, Marco A.;
Negri, Tiziana;
Tamborini, Elena;
Perrone, Federica;
Pricl, Sabrina;
Pilotti, Silvana

Publication type:

Article

The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia

Published in:

Molecular Oncology, 2008, v. 2, n. 3, p. 272, doi. 10.1016/j.molonc.2008.07.003

By:

Hantschel, Oliver;
Gstoettenbauer, Agnes;
Colinge, Jacques;
Kaupe, Ines;
Bilban, Martin;
Burkard, Thomas R.;
Valent, Peter;
Superti-Furga, Giulio

Publication type:

Article

Computational dissection of allosteric inhibition of the SH2 domain of Bcr-Abl kinase by the monobody inhibitor AS25.

Published in:

Journal of Molecular Modeling, 2017, v. 23, n. 6, p. 1, doi. 10.1007/s00894-017-3353-5

By:

Ji, Mingfei;
Zheng, Guodong;
Li, Xiaolong;
Zhang, Zhongqin;
Jv, Guanqun;
Wang, Xiaowei;
Wang, Jialin

Publication type:

Article

Ongoing Nursing Management of Cancer Survivors: Collaboration Between Oncology and Primary Care.

Published in:

2012

By:

Pieszak, Sean

Publication type:

Conference Paper/Materials

Apheresis principles in a patient with chronic myeloid leukemia during pregnancy: challenges in cell separation and assessing transcript levels.

Published in:

2019

By:

Lund, Kit Peiter;
Larsen, Maria Torp;
Haastrup, Eva Kannik;
Pedersen, Berit Woetman;
Maroun, Lisa Leth;
Andersen, Morten Tolstrup;
Bjerrum, Ole Weis;
Fischer‐Nielsen, Anne;
Fischer-Nielsen, Anne

Publication type:

Case Study

Spleen Rupture as the First Presentation of Chronic Phase Chronic Myeloid Leukemia. Case Report.

Published in:

2012

By:

Al Tameemi, Waseem F.;
Hamid, Maan M. A.

Publication type:

Case Study

Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines.

Published in:

Journal of Translational Medicine, 2008, v. 6, p. 1, doi. 10.1186/1479-5876-6-53

By:

Eustace, Alex J.;
Crown, John;
Clynes, Martin;
O'Donovan, Norma

Publication type:

Article

Eruption of squamous cell carcinomas after beginning nilotinib therapy.

Published in:

Dermatology Online Journal, 2020, v. 26, n. 6, p. 1, doi. 10.5070/d3266049318

By:

Crain, Caroline B.;
Winsett, Frank T.;
Woolridge, Katelyn F.;
Wilson, Janice M.;
Goodwin, Brandon P.

Publication type:

Article

The effect of nilotinib plus arsenic trioxide on the proliferation and differentiation of primary leukemic cells from patients with chronic myoloid leukemia in blast crisis.

Published in:

Cancer Cell International, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12935-015-0158-4

By:

Wei Wang;
Fei-fei Lv;
Yan Du;
Nannan Li;
YaLing Chen;
LiHong Chen

Publication type:

Article

Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells.

Published in:

Cancer Gene Therapy, 2013, v. 20, n. 7, p. 421, doi. 10.1038/cgt.2013.31

By:

Koldehoff, M.;
Zakrzewski, J. L.;
Beelen, D. W.;
Elmaagacli, A. H.

Publication type:

Article

Faktori koji utiču na postizanje i postojanost citogenetskog odgovora kod bolesnika sa hroničnom mijeloidnom leukemijom na terapiji imatinibom.

Published in:

Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2011, v. 68, n. 11, p. 911, doi. 10.2298/VSP1111911C

By:

Ćojbašić, Irena;
Mačukanović-Golubović, Lana

Publication type:

Article

miRNAs as Biomarkers in Chronic Myelogenous Leukemia.

Published in:

Drug Development Research, 2015, v. 76, n. 6, p. 278, doi. 10.1002/ddr.21266

By:

Kotagama, Kasuen;
Chang, Yung;
Mangone, Marco

Publication type:

Article

Adherence to TKI in CML patients: more than reports.

Published in:

2018

By:

Souza, Jessica de O.;
Busato, Fernanda de O.;
Frota, Isadora Duarte Santos;
Neves, Daniel Santos;
de Deus Santos, Marcelo Renan;
Olivieri, David N.;
Tadokoro, Carlos E.

Publication type:

Letter

How to report adherence to treatment as clinically relevant data-making a case of CML and TKI.

Published in:

2018

By:

Okumura, Lucas Miyake

Publication type:

Letter

The role of clinical pharmacists in treatment adherence: fast impact in suppression of chronic myeloid leukemia development and symptoms.

Published in:

2017

By:

Moulin, Silmara;
Eutrópio, Frederico;
Souza, Jessica;
Busato, Fernanda;
Olivieri, David;
Tadokoro, Carlos;
Moulin, Silmara Mendes Martins;
Eutrópio, Frederico Jacob;
Souza, Jessica de Oliveira;
Busato, Fernanda de Oliveira;
Olivieri, David N;
Tadokoro, Carlos Eduardo

Publication type:

journal article

Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis.

Published in:

2016

By:

Breccia, Massimo;
Graffigna, Guendalina;
Galimberti, Sara;
Iurlo, Alessandra;
Pungolino, Ester;
Pizzuti, Michele;
Maggi, Alessandro;
Falzetti, Franca;
Capalbo, Silvana;
Intermesoli, Tamara;
Maffioli, Margherita;
Elena, Chiara;
Melosi, Alessandro;
Simonetti, Federico;
Capochiani, Enrico;
Seta, Roberta;
Pacilli, Matteo;
Luppi, Mario;
Di Renzo, Nicola;
Mastrullo, Lucia

Publication type:

journal article

Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.

Published in:

Molecules, 2018, v. 23, n. 1, p. 119, doi. 10.3390/molecules23010119

By:

Maia, Raquel C.;
Vasconcelos, Flavia C.;
Souza, Paloma S.;
Rumjanek, Vivian M.

Publication type:

Article

Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC.

Published in:

Molecules, 2017, v. 22, n. 9, p. 1546, doi. 10.3390/molecules22091546

By:

Tegethoff, Jana;
Bischoff, Roland;
Saleh, Sawsan;
Blagojevic, Biljana;
Merz, Karl-Heinz;
Xinlai Cheng

Publication type:

Article

Design and Synthesis of Novel 2-Phenylaminopyrimidine (PAP) Derivatives and Their Antiproliferative Effects in Human Chronic Myeloid Leukemia Cells.

Published in:

Molecules, 2009, v. 14, n. 10, p. 4166, doi. 10.3390/molecules14104166

By:

Sheng Chang;
Shi-Liang Yin;
Jian Wang;
Yong-Kui Jing;
Jin-Hua Dong

Publication type:

Article

Why Doesn't Imatinib Cure Chronic Myeloid Leukemia?

Published in:

Oncologist, 2010, v. 15, n. 2, p. 182, doi. 10.1634/theoncologist.2009-0297

By:

Redner, Robert I.

Publication type:

Article